↓ Skip to main content

Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trial

Overview of attention for article published in Journal of Hematology & Oncology, August 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (76th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter
12 X users

Citations

dimensions_citation
37 Dimensions

Readers on

mendeley
41 Mendeley